Optimising patient centred drug development to realise impact.

There is also an increasing trend in use of clinical outcomes assessments, including PROs in FDA labels and health technology assessment submissions, in total and across most therapeutic areas, indicating a shift toward more patient centricity 7 .

also in 63,971 other papers